WOCKPHARMA - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.0
| Stock Code | WOCKPHARMA | Market Cap | 23,172 Cr. | Current Price | 1,425 ₹ | High / Low | 1,870 ₹ |
| Stock P/E | 79.4 | Book Value | 190 ₹ | Dividend Yield | 0.00 % | ROCE | 9.74 % |
| ROE | 9.99 % | Face Value | 5.00 ₹ | DMA 50 | 1,346 ₹ | DMA 200 | 1,367 ₹ |
| Chg in FII Hold | 0.09 % | Chg in DII Hold | 0.41 % | PAT Qtr | 132 Cr. | PAT Prev Qtr | 38.0 Cr. |
| RSI | 60.3 | MACD | 35.2 | Volume | 4,81,032 | Avg Vol 1Wk | 4,71,829 |
| Low price | 1,087 ₹ | High price | 1,870 ₹ | PEG Ratio | 1.64 | Debt to equity | 0.64 |
| 52w Index | 43.2 % | Qtr Profit Var | 230 % | EPS | 19.5 ₹ | Industry PE | 30.2 |
WOCKPHARMA shows mixed potential for swing trading. The RSI (60.3) indicates mild bullish momentum, while MACD (35.2) confirms strength. The stock is trading above its 50 DMA (1,346 ₹) and 200 DMA (1,367 ₹), suggesting short-term support. However, fundamentals are weak with ROCE (9.74%) and ROE (9.99%), and valuation is stretched (P/E 79.4 vs industry 30.2). Debt-to-equity ratio (0.64) is relatively high, adding risk. Quarterly PAT surged (132 Cr. vs 38 Cr.), but sustainability remains uncertain.
✅ Entry Price: Best entry zone is around 1,350–1,370 ₹, near DMA support.
📤 Exit Strategy: If already holding, aim to exit near 1,500–1,550 ₹ resistance, or cut losses if price falls below 1,320 ₹.
🌟 Positive
- Quarterly PAT growth of 230% shows strong short-term improvement.
- Stock trading above both 50 DMA and 200 DMA, confirming momentum.
- Institutional interest rising (FII +0.09%, DII +0.41%).
- 52-week return of 43.2% highlights investor confidence.
⚠️ Limitation
- High valuation with P/E at 79.4 vs industry 30.2.
- Weak ROCE (9.74%) and ROE (9.99%) indicate poor efficiency.
- Debt-to-equity ratio of 0.64 adds financial risk.
- No dividend yield, limiting investor appeal for income.
📰 Company Negative News
- No major negative news reported, but high debt and weak efficiency metrics remain concerns.
📈 Company Positive News
- Quarterly PAT surged significantly (132 Cr. vs 38 Cr.).
- Institutional holdings increased, showing renewed confidence.
- Momentum supported by strong trading volumes above weekly average.
🏭 Industry
- Industry P/E at 30.2 indicates moderate valuation.
- WOCKPHARMA trades at a steep premium, reflecting speculative interest.
🔎 Conclusion
WOCKPHARMA is a speculative swing trade candidate with strong short-term momentum and profit growth but weak fundamentals and high debt. Entry near 1,350–1,370 ₹ offers limited risk, while exit near 1,500–1,550 ₹ captures upside. Caution is advised due to stretched valuations and poor efficiency ratios.